Abstract
The present study was an attempt to formulate and evaluate enteric coated tablets for Esomeprazole magnesium dihydrate delayed release multi- particulate to reduce the Gastrointestinal tract side effects.The delayed release multiple units were prepared by using fluid-bed werster technology.These multiple units are selected by seal coating, drug coating and enteric coating.These Esomeprazole magnesium dehydrate were evaluated for assay, acid resistence, drug release,dissolution, Kinetic studies of Innovator and Optimized formulation, Stability studies of Optimized formulation. This study concluded Esomeprazole magnesium dihydrate can be prepared by using combination of polymers studied and we can reduce the GI tract side effects.
References
Ansel C.H., and Poppovich N.G. Pharmaceutical Dosage Forms and Drug Delivery Systems, 6th Ed. B.I. Waverly Pvt.Ltd, New Delhi: 1995 (Eds) 213.
Baert L., Vermeersch H., Remon J.P., 1993a. Smeyers- Verbeke, J. and Massart, D.L. Study of parameters important in the spheronization process. Int. J. Pharm. 96: 225-229.
Bataille B., Ligarski K., Jacob M., Thomas C., and Duru C., 1993. Study of the influence of spheronization and drying conditions on the physico-mechanical properties of neutral spheroids containing Avicel PH 101 and lactose. Drug Dev Ind Pharm. 19: 653-671.
Bauer K. H., Lehmann K., Osterwald H. P., Rothgang G. Equipment for sugar coating and film coating processes Coated pharmaceutical dosage forms. Medpharm Scientiphic Publishers, Stuttgart (1998).
Bianchini R., Bruni G., Gazzaniga A., and Vecchio C., Influence of extrusion-spheronization processing on the physical properties of d-indobufen pellets containing pH adjusters. Drug Dev. Ind. Pharm. 18: 1485-1503 (1992).
Brown C., Chokshi H., Nickerson B., Reed R., Rohrs B., Shah P. (2004). Acceptable analytical practices for dissolution testing of poorly soluble compounds. Pharmaceutical Technology.
Chen CY, Lu CL, Luo JC, Chang FY, Lee SD, Lai YL Esomeprazole tablet vs omeprazole capsule in treating erosive esophagitis. World J Gastroenterol. 11(20):3112-7.2005 May 28; Pub Med.
Costa F. O., Pais A. A. C. C., Sousa J. J. S. Analysis of formulation effects in the dissolution of ibuprofen pellets. International Journal of Pharmaceutics 270:9-19. (2004).
Dashevsky A., Wagner K., Kolter K., Bodmeier R. Physicochemical and release properties of pellets coated with Kolicoat SR 30D, a new aqueous polyvinyl acetate dispersion for extended release. International Journal of Pharmaceutics 290: 15-23. (2005).
javascript:tableWin()Digenis G.A., The in vivo behavior of multiparticulate versus single unit dosage formulations. In Ghebre-Sellassie, I., Ed. Multipaticulate Oral Drug Delivery. New York. Marcel Dekker: 333-355, 1994.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array